Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc (AMPH) Option Chain
As of September 17, 2026, Amphastar Pharmaceuticals Inc is trading at $23.63, a -0.80% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 36.4%. IV Rank is 0%.
Read more
Tracking the AMPH option chain helps you see every strike and expiry on Amphastar Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Amphastar Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of AMPH options activity at a glance. Use our scanner to monitor the AMPH option chain in real time and filter for the AMPH options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For AMPH stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the AMPH option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where AMPH stock options are being actively traded and where they are not.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.
The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Amphastar Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen AMPH options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of AMPH stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile25.00% Subdued
- Market cap (M$)1,013
- 52 weeks high-19.31%
- 52 weeks low43.15%
- Analyst recommendationHold
3.14 - Target price$22.50
-4.78% below the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-05
- P/E13.96
- Future P/E7.49
- EPS (ttm)1.71
- EPS growth next 5 years1.34%
As of September 17, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.00 | 4 | 0 | 0.17 | 6.13 | 4.20 | 8.40 | 17.50 | -26.53 | — | 1.50 | 0.00 | 1.50 | 0 | 8 | 100.00 |
| 0.00 | 14 | 0 | 0.37 | 3.63 | 2.10 | 5.90 | 20.00 | -16.04 | — | 3.40 | 0.00 | 3.40 | 0 | 4 | 100.00 |
| 0.01 | 197 | 0 | 0.02 | 1.13 | 0.05 | 2.25 | 22.50 | -5.54 | — | 0.40 | 0.00 | 0.40 | 0 | 10 | 99.99 |
| 99.91 | 15 | 0 | 0.40 | 0.00 | — | 0.40 | 25.00 | +4.95 | — | 3.70 | 1.37 | 2.33 | 0 | 1 | 0.10 |
| 100.00 | 22 | 0 | 1.15 | 0.00 | — | 1.15 | 30.00 | +25.94 | 4.10 | 8.30 | 6.37 | -0.17 | 0 | 1 | 0.00 |
As of September 17, 2026
Scan the full option chain in one place
Browse the full AMPH option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→